Clinical Presentation of IBD Flashcards
What is important regarding the pathophysiology as it relates to treatment for IBD?
- there is increased permeability within the tight junctions allowing pro-inflammatory cytokines to be activated (mainly TNF-a).
- circulating T cells with integrin-a4B7 bind to endothelial cells increasing entry of gut specific T cells.
Does decreased physical activity and obesity increase your risk for Crohn’s disease?
YES
How does ulcerative colitis present clinically?
- diarrhea (often bloody), frequent but small volume
- urgency
- colicky abdominal pain
- gradual and progressive onset
- in moderate to severe disease= fever, pallor, tenderness, and muscle wasting
Do most patients with ulcerative colitis present with mild disease?
YES= less than 5 stools/day, no systemic toxicity, and mild crampy pain.
What are the lab/imaging findings for acute ulcerative colitis?
- anemia
- elevated sed rate (always elevated for inflammation)
- low albumin
- electrolyte abnormalities
- elevated fecal calprotectin (BEST)
- p-ANCA
- thickened bowel wall on CT
- loss of haustra on barium swallow
How do you basically diagnose ulcerative colitis?
- exclude other causes (history, labs…)
- diarrhea greater than 4 weeks + active inflammation on colonoscopy + chronic changes on biopsy
What will you see on a colonoscopy for ulcerative colitis?
- loss of vascular markings (engorgement)
- erythema, granularity
- petechiae, exudates, edema, erosions, friability
- pseudopolyps
- profuse bleeding
- ALWAYS involves RECTUM and proceeds proximally in a circumferential pattern.
Do we always biopsy the ileum in IBD?
YES to help us discern whether it is Ulcerative colitis or Crohn’s disease
Do patients with just proctitis (inflammation of the rectum) have a more benign course in ulcerative colitis?
YES
What is the goal with treatment of ulcerative colitis?
heal the mucosa, thus decreasing the risk of colectomy (removal of colon).
What are the complications of ulcerative colitis?
- toxic megacolon (greater than 5 cm)= increased colonic diameter with systemic toxicity. This can lead to perforation (50% mortality).
- benign strictures (MALIGNANT mass until proven otherwise).
- dysplasia/colorectal cancer (highest risk in pancolitis).
What are the extraintestinal manifestations of ulcerative colitis? (see printout)
- PRIMARY SCLEROSING CHOLANGITIS= inflammation of intra and extra hepatic bile ducts leading to cholestasis (look for beaded strictures of bile ducts on ERCP). Independent of disease activity.
- ankylosing spondylitis (more in Crohn’s; independent of disease activity)
- peripheral arthritis (independent of disease activity)
- osteopenia/osteoporosis
- pyoderma gangrenosum (independent of disease activity).
- aphthous stomatitis (canker sores)
- sweets syndrome=sudden onset of fever, leukocytosis, and tender, red, well-demarcated papules and plaques (not specific to IBD).
- increased risk of venous thromboembolism
- hemolytic anemia
- uveitis (independent of disease activity)
- episcleritits
- erythema nodosum (more in Crohn’s)
Does treatment of IBD affect the course of primary sclerosing cholangitis?
NO
*you could take out the entire colon and you would still have primary sclerosing cholangitis.
Does primary sclerosing cholangitis increase your risk for colon cancer?
YES. Therefore you must get a colonoscopy every 1-2 years when you have this.
Is there a cure for IBD?
NO
What are the 2 goals for managing IBD?
- induce remission
2. maintain remission
What is mesalamine (5-ASA)?
- oral medication used ONLY for IBD, developed to prevent proximal absorption via ph and time dependence along with a colonic bacteria requirement for activation. Works by inhibitings pro-inflammatory cytokines, cause immunosuppression, free radial scavenger, and impairs leukocyte function.
- topical formulation via enema exists as well.
- used only for mild-moderate ULCERATIVE COLITIS (sometimes for crohn’s).
Does mesalamine reach past the splenic flexure?
NO
What is Azathioprine?
- rapidly metabolized to 6-mercaptopurine (6-MP), which inhibits proliferation of B and T cells, and causes apoptosis of T cells.
- TPMT (thiopurine S-methyltransferase) will convert 6-MP to an inactive metabolite. Thus TPMT must be measured in all pts prior to starting this drug.
If a pt has homozygous non-functional alleles for TPMT, can you use azathioprine?
NO
If a pt has heterozygous non-functional alleles for TPMT, can you use azathioprine?
YES but decrease the dose
What do we use to monitor drug levels of azathioprine?
6-thioguanine (6-TGN) to measure for toxic effects.
When is azathioprine used?
in pts who have steroid refractory UC and Crohn’s disease
*takes 6 months to take effect (usually used in combination with other drugs)
** What is a side effect of azathioprine? (TEST QUESTION)
hepatosplenic T cell lymphoma